It makes sure the benefits of the first treatment last longer
By using this blend in lab studies, researchers gain a dependable research tool
But potential means nothing if you shatter the molecular structure during reconstitution, contaminate the solution with bacteria, or miscalculate the concentration so badly that every dose is wrong from day one
Its structure is based primarily on the GIP amino-acid sequence and includes a C20 fatty-diacid moiety for albumin binding and DPP-4 resistance, giving it a reported half-life of about five days and supporting once-weekly administration in its trial programs
"Pentadecapeptide BPC 157 reduces bleeding and thrombocytopenia after amputation in rats treated with heparin, warfarin, L-NAME and L-arginine." PLoS ONE, 2020
Athletes subject to anti-doping testing should be aware that BPC-157 use violates anti-doping regulations and can result in adverse analytical findings